Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool

NCT02791217 is registered in ClinicalTrials.gov with Assuta Medical Center as lead sponsor.

NCT NCT02791217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02791217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Lead sponsor
Assuta Medical Center
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2016
Completion date
June 30, 2019
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma, hodgkin lymphoma, lymphoma, b-cell, multiple myeloma